PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Context
Botswana's blood supply has reached a plateau of approximately 20,000 units per annum, against a long-standing target of 34,000 units. Data collected by Botswana National Blood Transfusion Service (BNBTS) show that up to 29% of the available blood-supply is utilized to treat HIV related anemia.
Continuing Medical Education (CME) for clinicians remains a priority to promote the rational use of blood and blood products.
Safe Blood for Africa Foundation's (SBFA) mission is to facilitate capacity-building of blood services in Africa in order to deliver adequate, accessible and affordable safe blood through appropriate best practices.
SBFA has a strong staff and consultant database with unique experience in establishing sustainable blood services in Africa.
Since 2004, SBFA has been receiving Track 1 PEPFAR funding to provide technical assistance to the BNBTS.
Goals and Objectives
To support BNBTS and the Botswana Ministry of Health to achieve a safe and adequate supply of blood to meet the estimated annual national need of 34,000 units
Major Activities
SBFA will work toward implementation of the revised Transfusion Transmissible Infections testing strategy, provide training and guidance on the implementation of the National Quality Program for the BNBTS, support the introduction of the revised National Blood Policy, finalize the updated Clinical Guidelines (in collaboration with the National Committee on the Clinical Use of Blood), ensure distribution of the revised guidelines to each public-service doctor who practices transfusion medicine, and engage an external consultant to assess the project.
SBFA will assist BNBTS to increase the supply of safe blood for Botswana's clinical treatment programs.
Blood donors will be rigorously counseled and screened for HIV and other Transfusion Transmissible Infections.
Medical personnel from all hospitals will be targeted for training in rational clinical use of blood, and will receive updated clinical guidelines on blood transfusion.
Target Population
The estimated 10,000 to 15,000 patients per annum who require blood transfusions. These include the estimated 3,000 patients in treatment programs who require transfusion for severe HIV-related anemia
Maternity cases requiring transfusion for hemorrhage
The eligible donor community, including military populations
Medical personnel from all hospitals
Geographic coverage
All 32 hospitals and healthcare facilities which provide blood for transfusion
Cross-Cutting Areas
SBFA activities support HIV-prevention through blood-donor programs which promote healthy lifestyles, low-risk behavior, counseling and testing, and referral for HIV positive donors.
SBFA activities support HIV treatment by assuring a critical supply of safe blood to treat severe HIV-related anemia.
SBFA activities support malaria prevention and treatment where safe transfusion is essential for preventing infection and for treating severe malaria-related anemia.
SBFA activities support safe motherhood by providing blood for maternal hemorrhage and pediatric transfusion.
SBFA activities support all the above by training clinicians in transfusion medicine.
Enhancing Sustainability
SBFA works with BNBTS staff and clinicians from all hospitals to provide blood for transfusion
In line with the intention of BNBTS (and PEPFAR) to develop and implement total quality management systems (QMS), additional technical assistance (TA) resources have been allocated to accelerating QMS in BNBTS. This directly supports the sustainable delivery of a safe and high-quality service for Botswana's hospitals.
The sustainability of BNBTS is largely dependant upon its human-resource capacity. Permanent staff appointments, particularly fulltime leadership of BNBTS, are a remaining challenge. Essential posts such as a fulltime Medical Director need to be filled. SBFA will provide TA in FY10, for the Medical Director post to be advertised, a candidate appointed, and training commenced.
Monitoring and Evaluation (M&E)
SBFA will ensure proper M&E of PEPFAR indicators for blood safety, and will support operational research to gather data to quantify the demand for blood and blood-products related to HIV treatment programs.
In the Project close-out period, an independent end-of-program evaluation will identify remaining priorities and direct future Blood Safety activity.
